Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization

YUN-TING LIN, JENG-WEI LU, JUNG-CHUN LIN, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, HSIAO-CHEN LIU, KUANG-YIH WANG and FENG-CHENG LIU
In Vivo May 2025, 39 (3) 1669-1675; DOI: https://doi.org/10.21873/invivo.13968
YUN-TING LIN
1Department of General Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JENG-WEI LU
2Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, R.O.C.;
3Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark;
4The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNG-CHUN LIN
5Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YI-JUNG HO
6School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
7Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHAN-WEN LUI
8Department of Internal Medicine, Linkou Chang-Gung Memorial Hospital, Taoyuan, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TING-YU HSIEH
9Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HSIAO-CHEN LIU
10Department of Biotechnology, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KUANG-YIH WANG
11Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FENG-CHENG LIU
11Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lfc10399{at}yahoo.com.tw
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 39 no. 3 1669-1675
DOI 
https://doi.org/10.21873/invivo.13968
PMID 
40295001

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received February 4, 2025
  • Revision received February 18, 2025
  • Accepted February 19, 2025
  • Published online April 28, 2025.

Copyright & License 
Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. YUN-TING LIN1,
  2. JENG-WEI LU2,3,4,
  3. JUNG-CHUN LIN5,
  4. YI-JUNG HO6,7,
  5. SHAN-WEN LUI8,
  6. TING-YU HSIEH9,
  7. HSIAO-CHEN LIU10,
  8. KUANG-YIH WANG11 and
  9. FENG-CHENG LIU11⇑
  1. 1Department of General Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  2. 2Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, R.O.C.;
  3. 3Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark;
  4. 4The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
  5. 5Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  6. 6School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  7. 7Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  8. 8Department of Internal Medicine, Linkou Chang-Gung Memorial Hospital, Taoyuan, Taiwan, R.O.C.;
  9. 9Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;
  10. 10Department of Biotechnology, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.;
  11. 11Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  1. Feng-Cheng Liu, MD, Ph.D., Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan, R.O.C. Tel: +886 287923100 ext. 12588, e-mail: lfc10399{at}yahoo.com.tw
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo: 39 (3)
In Vivo
Vol. 39, Issue 3
May-June 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization
YUN-TING LIN, JENG-WEI LU, JUNG-CHUN LIN, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, HSIAO-CHEN LIU, KUANG-YIH WANG, FENG-CHENG LIU
In Vivo May 2025, 39 (3) 1669-1675; DOI: 10.21873/invivo.13968

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization
YUN-TING LIN, JENG-WEI LU, JUNG-CHUN LIN, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, HSIAO-CHEN LIU, KUANG-YIH WANG, FENG-CHENG LIU
In Vivo May 2025, 39 (3) 1669-1675; DOI: 10.21873/invivo.13968
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Case Report
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical Evaluation Versus Clinical Evaluation With Dermoscopy in Malignant Skin Neoplasms Diagnosis
  • Clinical Utility of Body Weight Monitoring During Cisplatin-based Chemotherapy
  • NLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder
Show more Clinical Studies

Keywords

  • Primary biliary cholangitis
  • molecular hydrogen
  • liver enzymes
  • IgG4
  • oxidative stress
  • immune modulation
In Vivo

© 2026 In Vivo

Powered by HighWire